专题：Health Systems, Economic Evaluations, Quality of Life

This cluster of papers focuses on the intersection of health economics and quality of life assessment, with a particular emphasis on cost-effectiveness analysis, health utility measures such as EQ-5D and SF-36, quality-adjusted life years (QALY), health technology assessment, and preference-based measures for evaluating the economic impact of healthcare interventions.
最新文献
Innovation networks in the advanced medical equipment industry: supporting regional digital health systems from a local–national perspective

article Full Text OpenAlex

JSH2025 guidelines new viewpoints

editorial Full Text OpenAlex

Direct-to-consumer self-tests sold in the UK in 2023: cross sectional review of regulation and evidence of performance

review Full Text OpenAlex

Life’s Crucial 9, Genetic Susceptibility, and the Risk of Atrial Fibrillation: A Prospective Study in the UK Biobank Cohort

article Full Text OpenAlex

Global Impact of Fixed-Dose Combination Therapies on Cardiovascular Mortality and Events, 2023-2050

article Full Text OpenAlex

Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study

article Full Text OpenAlex

Defining Health Care “Corporatization”

article Full Text OpenAlex

Lived experience perspectives about gaps and barriers in services for those living with, and those providing care, for people with young-onset dementia in Australia: Findings from the Joint Solutions Project

article Full Text OpenAlex

Effect Size Guidelines for Individual and Group Differences in Physiotherapy

article Full Text OpenAlex

Global Diseases Deserve Global Solutions: Alzheimer’s Disease

review Full Text OpenAlex

近5年高被引文献
Difference-in-differences with variation in treatment timing

article Full Text OpenAlex 4936 FWCI594.307

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

article Full Text OpenAlex 4782 FWCI688.503

A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance

article Full Text OpenAlex 3938 FWCI877.188

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

article Full Text OpenAlex 3522 FWCI640.798

2023 Alzheimer's disease facts and figures

article Full Text OpenAlex 2391 FWCI771.117

Donanemab in Early Symptomatic Alzheimer Disease

article Full Text OpenAlex 1528 FWCI406.765

The Overview on Effectiveness of Quality Enhancement for Enhancing Health Care and Professional Practice

article Full Text OpenAlex 960 FWCI701.652

Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

article Full Text OpenAlex 861 FWCI222.731

Best practice guidance and reporting items for the development of scoping review protocols

article Full Text OpenAlex 824 FWCI114.825

American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults

article Full Text OpenAlex 782 FWCI196.152